One hypothesis to explain the high level of TYRA in DN patients, that is even more elevated in the treated PD patients, is that the activity of AADC enzyme is increased, an event which may reflects the reduced energy availability and mitochondrial dysfunction reported in PD24–26. This evidence concerns the gene DDC and Parkinson disease.